FAKTOR-OPTIONSSCHEIN - MERCK & CO. Share Price

Certificat

DE000SV4AQZ7

Delayed Deutsche Boerse AG 14:46:18 28/05/2024 BST
9.25 EUR +0.98% Intraday chart for FAKTOR-OPTIONSSCHEIN - MERCK & CO.
Current month-1.40%
1 month+0.55%
Date Price Change
28/05/24 9.25 +0.98%
27/05/24 9.16 +0.22%
24/05/24 9.14 +0.88%
23/05/24 9.06 +0.22%
22/05/24 9.04 +0.11%

Delayed Quote Deutsche Boerse AG

Last update May 28, 2024 at 02:46 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer Société Générale Société Générale
WKN SV4AQZ
ISINDE000SV4AQZ7
Date issued 14/04/2023
Strike 113.8 $
Maturity Unlimited
Parity 1 : 1
Emission price 9.96
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 12.08
Lowest since issue 8.87
Spread 0.01
Spread %0.11%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
129.5 USD
Average target price
141.9 USD
Spread / Average Target
+9.57%
Consensus